These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 31058560)
41. Dutasteride reduces prostate size and prostate specific antigen in older hypogonadal men with benign prostatic hyperplasia undergoing testosterone replacement therapy. Page ST; Hirano L; Gilchriest J; Dighe M; Amory JK; Marck BT; Matsumoto AM J Urol; 2011 Jul; 186(1):191-7. PubMed ID: 21575967 [TBL] [Abstract][Full Text] [Related]
42. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Roehrborn CG; Boyle P; Gould AL; Waldstreicher J Urology; 1999 Mar; 53(3):581-9. PubMed ID: 10096388 [TBL] [Abstract][Full Text] [Related]
43. Relationship among diet habit and lower urinary tract symptoms and sexual function in outpatient-based males with LUTS/BPH: a multiregional and cross-sectional study in China. Chen Y; Yu W; Zhou L; Wu S; Yang Y; Wang J; Tian Y; He D; Xu Y; Huang J; Wang X; Gao X; Li H; Ma L; Zhang N; Zhao S; Jin X BMJ Open; 2016 Aug; 6(8):e010863. PubMed ID: 27580828 [TBL] [Abstract][Full Text] [Related]
44. Testosterone and Benign Prostatic Hyperplasia. Rastrelli G; Vignozzi L; Corona G; Maggi M Sex Med Rev; 2019 Apr; 7(2):259-271. PubMed ID: 30803920 [TBL] [Abstract][Full Text] [Related]
45. Additional value of the ratio of serum total testosterone to total prostate-specific antigen in the diagnosis of prostate cancer in a Chinese population. Xu L; Hu X; Zhu Y; Lu J; Xu Y; Wang G; Guo J Andrologia; 2018 Mar; 50(2):. PubMed ID: 28752596 [TBL] [Abstract][Full Text] [Related]
46. Relationship between serum testosterone and nocturia in men without benign prostate enlargement. Jeh SU; Yoon S; Seo DH; Lee SW; Lee C; Choi SM; Kam SC; Hwa JS; Chung KH; Hyun JS Andrology; 2017 Jan; 5(1):58-62. PubMed ID: 27636882 [TBL] [Abstract][Full Text] [Related]
47. Serum lipid levels in benign prostatic hyperplasia. Lekili M; Müezzinoğlu T; Uyanik BS; Büyüksu C World J Urol; 2006 Jun; 24(2):210-3. PubMed ID: 16506048 [TBL] [Abstract][Full Text] [Related]
48. Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia. Hong SK; Min GE; Ha SB; Doo SH; Kang MY; Park HJ; Yoon CY; Jeong SJ; Byun SS; Lee SE BJU Int; 2010 Apr; 105(7):970-4. PubMed ID: 19793378 [TBL] [Abstract][Full Text] [Related]
49. Effects of androgen deficiency and replacement on prostate zonal volumes. Jin B; Conway AJ; Handelsman DJ Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778 [TBL] [Abstract][Full Text] [Related]
50. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen]. Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904 [TBL] [Abstract][Full Text] [Related]
51. Obesity and benign prostatic enlargement: a large observational study in China. Xie LP; Bai Y; Zhang XZ; Zheng XY; Yao KS; Xu L; Zeegers MP Urology; 2007 Apr; 69(4):680-4. PubMed ID: 17445651 [TBL] [Abstract][Full Text] [Related]
52. Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching. Xiong Y; Zhang YC; Jin T; Qin F; Yuan JH Asian J Androl; 2021; 23(6):633-639. PubMed ID: 33818525 [TBL] [Abstract][Full Text] [Related]
53. Testosterone supplementation does not worsen lower urinary tract symptoms. Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078 [TBL] [Abstract][Full Text] [Related]
54. Serum Testosterone Levels Are Negatively Correlated with International Prostate Symptom Score and Transitional Prostate Volume. Shim JS; Kim JH; Yoon YS; Choi H; Park JY; Bae JH Low Urin Tract Symptoms; 2018 May; 10(2):143-147. PubMed ID: 29664237 [TBL] [Abstract][Full Text] [Related]
55. Vitamin D Deficiency as a Potential Marker of Benign Prostatic Hyperplasia. Zhang W; Zheng X; Wang Y; Xiao H Urology; 2016 Nov; 97():212-218. PubMed ID: 27327576 [TBL] [Abstract][Full Text] [Related]
56. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years. Liao CH; Li HY; Chung SD; Chiang HS; Yu HJ Aging Male; 2012 Mar; 15(1):28-33. PubMed ID: 21247242 [TBL] [Abstract][Full Text] [Related]
57. Association between Benign Prostatic Hyperplasia and Neutrophil-Lymphocyte Ratio, an Indicator of Inflammation and Metabolic Syndrome. Ozer K; Horsanali MO; Gorgel SN; Horsanali BO; Ozbek E Urol Int; 2017; 98(4):466-471. PubMed ID: 27464069 [TBL] [Abstract][Full Text] [Related]
58. Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas. Yue L; Wang T; Ge Y; Ge M; Zhang C; Hou Q; Wang W; Tian H; Ren B; Du B; Zhang W Prostate; 2019 Feb; 79(3):312-319. PubMed ID: 30450670 [TBL] [Abstract][Full Text] [Related]
59. Body mass index and age are predictors for symptom improvement after high-power laser vaporization for benign prostatic hyperplasia. Yang TK; Hsiao PJ; Yang HJ; Liao CH; Chiang HS; Chien KL J Formos Med Assoc; 2015 Mar; 114(3):268-73. PubMed ID: 25777976 [TBL] [Abstract][Full Text] [Related]
60. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. Meigs JB; Mohr B; Barry MJ; Collins MM; McKinlay JB J Clin Epidemiol; 2001 Sep; 54(9):935-44. PubMed ID: 11520654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]